Literature DB >> 9257730

Expression of cartilage oligomeric matrix protein by human synovium.

P E Di Cesare1, C S Carlson, E S Stollerman, F S Chen, M Leslie, R Perris.   

Abstract

Human synovium was analyzed for the possible expression of cartilage oligomeric matrix protein (COMP). Immunostaining with polyclonal antiserum to COMP demonstrated positive staining within the synovial cells and immediately subjacent connective tissue, with less intense staining in the deeper connective tissue. Western blot analysis using either polyclonal or monoclonal antibodies to human COMP confirmed the presence of COMP by immunoreactive bands with the same molecular mass (approximately 110 kDa) as purified articular cartilage COMP. PCR using oligonucleotides that span human COMP exons 7-13 revealed identical amplification products from cDNA prepared from either human chondrocytes or synovium. Northern blot analysis using a biotinylated-probe to human COMP, spanning exons 12-13, also reveal an identical hybridization product to either human chondrocyte or synovium total RNA. Human synovium should be considered as a potential tissue source of COMP in any investigation of biological markers of cartilage metabolism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257730     DOI: 10.1016/s0014-5793(97)00789-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

1.  Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins.

Authors:  Faye Hui Chen; Ashby O Thomas; Jacqueline T Hecht; Mary B Goldring; Jack Lawler
Journal:  J Biol Chem       Date:  2005-07-28       Impact factor: 5.157

2.  Mutant cartilage oligomeric matrix protein (COMP) compromises bone integrity, joint function and the balance between adipogenesis and osteogenesis.

Authors:  Francoise Coustry; Karen L Posey; Tristan Maerz; Kevin Baker; Annie M Abraham; Catherine G Ambrose; Sabah Nobakhti; Sandra J Shefelbine; Xiaohong Bi; Michael Newton; Karissa Gawronski; Lindsay Remer; Alka C Veerisetty; Mohammad G Hossain; Frankie Chiu; Jacqueline T Hecht
Journal:  Matrix Biol       Date:  2018-01-05       Impact factor: 11.583

3.  Proteomic analysis of Col11a1-associated protein complexes.

Authors:  Raquel J Brown; Christopher Mallory; Owen M McDougal; Julia Thom Oxford
Journal:  Proteomics       Date:  2011-11-23       Impact factor: 3.984

Review 4.  Cartilage oligomeric matrix protein: COMPopathies and beyond.

Authors:  Karen L Posey; Francoise Coustry; Jacqueline T Hecht
Journal:  Matrix Biol       Date:  2018-03-09       Impact factor: 11.583

Review 5.  Progranulin: a promising therapeutic target for rheumatoid arthritis.

Authors:  Chuan-ju Liu
Journal:  FEBS Lett       Date:  2011-05-04       Impact factor: 4.124

6.  Increased serum cartilage oligomeric matrix protein levels and decreased patellar bone mineral density in patients with chondromalacia patellae.

Authors:  E Murphy; O FitzGerald; T Saxne; B Bresnihan
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

7.  ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein.

Authors:  Chuan-Ju Liu; Wei Kong; Kiril Ilalov; Shuang Yu; Ke Xu; Lisa Prazak; Marc Fajardo; Bantoo Sehgal; Paul E Di Cesare
Journal:  FASEB J       Date:  2006-04-03       Impact factor: 5.191

8.  Enhancing and maintaining chondrogenesis of synovial fibroblasts by cartilage extracellular matrix protein matrilins.

Authors:  M Pei; J Luo; Q Chen
Journal:  Osteoarthritis Cartilage       Date:  2008-02-20       Impact factor: 6.576

9.  Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis.

Authors:  R K Chaganti; A Kelman; L Lui; W Yao; M K Javaid; D Bauer; M Nevitt; N E Lane
Journal:  Osteoarthritis Cartilage       Date:  2007-10-22       Impact factor: 6.576

10.  Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats.

Authors:  S Carlsén; A S Hansson; H Olsson; D Heinegård; R Holmdahl
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.